Proxibarbital: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 26: | Line 26: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{ | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 33: | Line 34: | ||
== References == | == References == | ||
{{reflist|2}} | |||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category:Drug]] | |||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
Latest revision as of 14:29, 8 April 2015
 | |
| Clinical data | |
|---|---|
| Synonyms | Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H14N2O4 |
| Molar mass | 226.229 g/mol |
|
WikiDoc Resources for Proxibarbital |
|
Articles |
|---|
|
Most recent articles on Proxibarbital Most cited articles on Proxibarbital |
|
Media |
|
Powerpoint slides on Proxibarbital |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Proxibarbital at Clinical Trials.gov Trial results on Proxibarbital Clinical Trials on Proxibarbital at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Proxibarbital NICE Guidance on Proxibarbital
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Proxibarbital Discussion groups on Proxibarbital Patient Handouts on Proxibarbital Directions to Hospitals Treating Proxibarbital Risk calculators and risk factors for Proxibarbital
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Proxibarbital |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Proxibarbital (Ipronal) is a barbiturate derivative invented in the 1970s. It has sedative, hypnotic and anticonvulsant properties, and was used in the treatment of migraine headaches in a similar manner to butalbital.[1]
References
- ↑ Sulman FG, Pfeifer Y, Tal E. Migraine therapy by enzyme induction with proxibarbital (German). Therapie die Gegenwart. 1976 Dec;115(12):2088-103.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Barbiturates
- Drug
- Sedatives